Latest News of CSL
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
By Yahoo! Finance |
1 day ago
Bird flu has been detected in 254 dairy herds across 14 states in the US. 16 human cases of H5 have been reported in 2024, leading to a collaboration between GSK, Sanofi, and CSL to produce vaccine co...
Sanofi, GSK, CSL Tapped to Expand US Bird Flu Vaccine Supply
By Yahoo! Finance |
1 day ago
GSK, Sanofi, and CSL received $72 million from the US government to boost bird flu vaccine production due to a nationwide outbreak. The aim is to increase the supply to 10 million doses by Q1 2025....
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
By Yahoo! Finance |
5 days ago
A study found that the sa-mRNA COVID-19 vaccine is more effective than Comirnaty against various variants at one-sixth the dose. The sa-mRNA vaccine Kostaive is approved in Japan. ARCT-2301 also shows...
-
Exploring Snt DynamicsLtd And 2 Other Hidden Small Caps in South Korea
By Yahoo! Finance | 1 week agoThe South Korea stock market has seen a positive trend recently, with investors eyeing small-cap stocks for growth opportunities. Promising companies like Snt Dynamics Ltd, Boryung Corporation, and Il...
-
Is Oaktree Specialty Lending Corporation (OCSL) the Best BDC Stocks To Invest In?
By Yahoo! Finance | 2 weeks agoThe article discusses the significance of Business Development Companies (BDCs) as investment options, highlighting Oaktree Specialty Lending Corporation (NASDAQ:OCSL) among the top 10 BDC stocks....
-
CSL (ASX:CSL) Ticks All The Boxes When It Comes To Earnings Growth
By Yahoo! Finance | 1 month agoInvestors often get swayed by compelling narratives of loss-making companies, risking emotional investments. However, profitable companies like CSL (ASX:CSL) offer more stable growth potential....
-
Complete Solaria, Inc.'s (NASDAQ:CSLR) Path To Profitability
By Yahoo! Finance | 1 month agoComplete Solaria, Inc. is a US-based company providing solar solutions with a market cap of US$79m. Analysts predict the company will break even in 2026 after a loss of US$97m in the latest financial ...
-
CSL Full Year 2024 Earnings: EPS Misses Expectations
By Yahoo! Finance | 1 month agoProfit margin increased to 18% from 17% in FY 2023 due to higher revenue. CSL's revenue was in line with estimates, but EPS missed by 3.2%. Revenue was driven by CSL Behring segment, while Sales & Mar...
-
The CSL Limited (ASX:CSL) Yearly Results Are Out And Analysts Have Published New Forecasts
By Yahoo! Finance | 1 month agoCSL Limited recently reported its annual results, causing shares to drop by 2.5%. Analysts predict a 6.4% revenue growth by 2025, with EPS expected to increase by 21%. Despite lower EPS forecasts, the...
-
Carlisle Companies' (NYSE:CSL) Shareholders Will Receive A Bigger Dividend Than Last Year
By Yahoo! Finance | 2 months agoCarlisle Companies Incorporated (NYSE: CSL) is increasing its dividend to $1.00 on September 3, up 18% from last year. Despite the low 0....
-
Is There An Opportunity With CSL Limited's (ASX:CSL) 27% Undervaluation?
By Yahoo! Finance | 2 months agoThe fair value estimate for CSL Limited is 30% higher than the analyst price target. A Discounted Cash Flow (DCF) model is used to evaluate the company's future cash flows and present value....
-
Decoding Carlisle Companies Inc (CSL): A Strategic SWOT Insight
By Yahoo! Finance | 2 months agoCSL's financial performance shows growth, with revenues and operating income increasing. The company's market leadership, strong brand reputation, and strategic acquisitions contribute to its success....
-
Here's Why Madison Mid Cap Fund Trimmed Carlisle Companies Incorporated (CSL)
By Yahoo! Finance | 2 months agoMadison Investments reported a 4.30% decline in its "Madison Mid Cap Fund" in Q2 2024. The fund's top pick, Carlisle Companies Inc., saw a 2.88% one-month return and 59.00% gain over 52 weeks....
-
Those who invested in CSL (ASX:CSL) five years ago are up 42%
By Yahoo! Finance | 3 months agoActive stock picking aims to outperform the market average by finding undervalued companies. CSL's share price growth of 34% in five years reflects investor sentiment aligning with the company's EPS g...
-
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
By Yahoo! Finance | 3 months agoCSL Behring announced the first real-world use of gene therapy HEMGENIX in treating hemophilia B patients in Europe, offering a one-time treatment to produce Factor IX and reduce bleeding risk. The th...